CNTX - Context Therapeutics rises on submission of IND application for its Claudin 6-positive cancers treatment April, 01 2024 09:11 AM Context Therapeutics Inc. 2024-04-01 09:11:44 ET More on Context Therapeutics Seeking Alpha’s Quant Rating on Context Therapeutics Historical earnings data for Context Therapeutics Financial information for Context Therapeutics For further details see: Context Therapeutics rises on submission of IND application for its Claudin 6-positive cancers treatment